Baltimore study enlists peers to fight HIV and overdose among drug users
NCT ID NCT05320835
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study tests whether a peer-driven program can help people who inject drugs in Baltimore reduce their risk of HIV, hepatitis C, and overdose. Researchers will identify high-risk injection settings and train peers to promote safer practices, like carrying naloxone and avoiding shared cookers. The study enrolls 285 current opioid users and tracks changes in prevention behaviors over time.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- peer-driven behavioral intervention
- What this could lead to
- If successful, this could point toward a scalable community-based strategy to reduce HIV, hepatitis C, and overdose in high-risk populations.
- What could go wrong
- This is a small pilot study (285 participants) in one city, so results may not apply elsewhere. The intervention relies on peer networks, which may be hard to sustain or replicate.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRUG OVERDOSE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Lighthouse Studies at Peer Point
RECRUITINGBaltimore, Maryland, 21205, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a once-weekly antibiotic help people with opioid use disorder beat serious infections at home?
- Could a diabetes drug curb opioid addiction? a trial puts semaglutide to the test
- Can a simple guide help clinicians better address youth substance use?
- Peer-led prevention: can gancheros help stop HIV, hepatitis c, and overdose in NYC?
- Small cash rewards may keep HIV-positive mothers in treatment — a trial puts the idea to the test
- Home-Based parenting program aims to strengthen bonds for mothers in recovery